Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Vaccine

Dr. Vinay Prasad: Stop Trusting the Public Health Establishment

Join Reason on YouTube at 1 p.m. Eastern for a discussion of mRNA vaccines and America's public health establishment with UCSF's Vinay Prasad.

Reason

Laurence Fox's GB News show struck by Ofcom complaints over Covid pregnancy claims

GB News came under fire from viewers over an interview in which Dr Tina Peers claimed 58% of women suffered a miscarriage during the Pfizer Covid vaccine trial

Daily Mirror

Mum given months to live after 'Covid jab side effect' turns out to be cancer

Katie Pritchard, from Tysoe, Stratford-upon-Avon, was told her cancer symptoms were just the side effects of her Covid vaccine or a prolapsed bladder following childbirth before she was given just months to live

Daily Mirror

From analysis to the latest developments in health,
read the most diverse news in one place.

Stocks Nudge Higher, Novavax, HP, Lowe's, Salesforce in Focus - Five Things To Know

Stocks nudge higher on strong China data after February slump; Novavax plunges as vaccine maker casts doubt on company's future; HP shares get boost from solid profit outlook, cost-cutting; Lowe's earnings on deck after muted Home Depot spending outlook and Salesforce earnings to highlight extent of activist pressure on CEO…

The Street

Joe Battenfeld: Origins of COVID the latest 'conspiracy theory' proved right

A report that the COVID-19 virus leaked from a lab in China is the latest former right wing “conspiracy theory” that’s gaining traction and undermining trust in government.

Boston Herald

Vaccine maker Novavax says 'substantial doubt' over future

Washington (AFP) - Covid-19 vaccine maker Novavax raised doubts Tuesday about its ability to continue its business, announcing plans to cut spending after struggles in rolling out its coronavirus jab.

AFP

Troops who refused COVID vaccine still may face discipline

Defense officials are telling Congress that the military services are still reviewing possible discipline of troops who refused the order to get the COVID-19 vaccine

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Pfizer’s RSV vaccine just won an FDA panel’s backing for safety in older people. It's a market that will be worth up to $10 billion in a decade

Pfizer is also facing off with collaborators Sanofi and AstraZeneca Plc to develop prevention for dangerous RSV infections in newborns, a market that could reach $1.5 billion.

Fortune

Government has wasted £26.8 billion under Sunak’s watch, says Labour

The party compiled a ‘catalogue of waste’ from the PM’s time as Chancellor and Chief Secretary to the Treasury.

The Independent UK

FDA panel narrowly backs Pfizer RSV vaccine for older adults

Federal health advisers have narrowly backed an experimental vaccine from Pfizer that could become the first shot to protect older adults against the respiratory illness known as RSV

The Independent UK

Pfizer’s RSV vaccine wins US panel’s backing for safety in older people

WASHINGTON — Pfizer Inc.’s vaccine for respiratory syncytial virus received endorsement from a key panel of U.S. advisers for its safety in people 60 and older, a key endorsement for the drugmaker’s potential product.

Tribune News Service

Families go to court after nurse in Spain accused of faking children’s jabs

Vaccine status of more than 400 children near Bilbao investigated amid concerns about anti-vaxxer nurse

The Guardian - UK

The Shot Boosters

Vaccines are under attack in Texas, and public health experts warn we'll pay a price in more outbreaks and deaths from preventable diseases.

Texas Observer

Victoria boosts Japanese encephalitis vax eligibility

Victoria has expanded Japanese encephalitis vaccine eligibility to include more local government areas, after data indicated broader infection in the community.

AAP

Get all your
news in one place.

100’s of premium titles.
One news app.

Bangkok Post

Dept issues reassurance about mRNA jabs' safety

The Department of Disease Control (DDC) has moved to dispel concerns about the efficacy and safety of both monovalent and bivalent mRNA vaccines for Covid-19, after reports of adverse side-effects made the rounds on social media.

Los Angeles Times

Woody Harrelson's 'SNL' monologue sparks backlash online: 'Antivax nonsense'

Woody Harrelson, who has a history of spreading COVID-19 conspiracy theories, has drawn criticism for appearing to denounce pandemic safety measures and vaccines during his "Saturday Night Live" monologue this weekend.

AAP

NSW premier laments continuing COVID vaccine mandates

The premier of NSW says there is no evidence vaccines currently have any impact on COVID-19 transmission, and has called for the end of broad vaccine mandates.

The Conversation

Is there a vaccine for RSV or respiratory syncytial virus? After almost 60 years, several come at once

You might not have heard of respiratory syncytial virus, or RSV. But it caused more than 100,000 global deaths in 2019, making it a leading cause of death in children under one year old.

Get all your
news in one place.

100’s of premium titles.
One news app.

Salon

"SNL" riffs on Trump, weed & vaccines

Host Woody Harrelson made comments during his monologue that left viewers wondering if he's anti-vax

Tribune News Service

FDA warns of Guillain-Barre syndrome as possible risk of Pfizer’s RSV vaccine

The Food and Drug Administration has flagged Guillain-Barre syndrome, a rare neurological condition, as a potential risk for Pfizer’s respiratory syncytial virus vaccine.

Investors Business Daily

The Next Generation Of Cancer Vaccines Is Coming; What That Means For Moderna And Other Biotech Stocks

Startling cancer vaccine results from Moderna could drive the company's second act and usher in the next big thing in biotech. Here's what you need to know.

The Guardian - UK

Stephen Jarrett obituary

Other lives: Unicef employee for 38 years who eventually specialised in the procurement and global supply of vaccines

Tribune News Service

Editorial: The risk of vaccine hesitancy

One of the lingering — and potentially disastrous — effects of the COVID pandemic is that more parents are reluctant to have their children vaccinated against what used to be common childhood diseases, as well as against flu and the mutating coronavirus strains.

Reuters

Flu experts gather with H5N1 risk on the agenda

The world's leading experts on influenza met this week to discuss the threat posed to humans by a strain of H5N1 avian flu that has caused record numbers of bird deaths around the world in recent months.

Chicago Sun-Times

RSV vaccines for babies, adults on the way. Here’s what could be coming.

Respiratory syncytial virus infects nearly everyone by age 2, usually causing nothing beyond cold symptoms. But it’s also the top cause of hospitalizations among kids under 5.

1 … 73 74 75 76

People

Tares Krassanairawiwong

24 stories

Deborah Friedman

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

332 stories

GSK

318 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.